The Massachusetts chapter of The Leukemia & Lymphoma Society (LLS) named
Julian Adams, Ph.D., of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) as
corporate chair of its 2014 Light The Night® Walk, LLS’s
annual fundraising event for cancer research and patient services. Dr.
Adams serves as president, research and development, at Infinity and is
responsible for the full spectrum of the company’s drug discovery,
preclinical and clinical development strategy and regulatory affairs
activities.
LLS holds walks each fall in approximately 200 communities across the
United States and Canada. Participants at the walks carry illuminated
balloons – white for survivors, red for supporters, and gold to remember
those who have died – to honor and commemorate lives touched by blood
cancer.
“Forming Light The Night Walk teams is a great way to build team spirit
among employees, raise awareness about the need for more blood cancer
therapies and recognize those who continue to be affected by these
diseases,” said Dr. Adams. “These same objectives – and our desire to
continue our support of LLS – led us to recently launch Infinity
Pharmaceuticals’ “Sparks
of Inspiration” campaign. I am honored to serve as the chair of the
2014 Light The Night Walk and look forward to helping more local
businesses and corporations get their employees involved.”
Prior to joining Infinity in 2003, Dr. Adams served as senior vice
president, drug discovery and development at Millennium Pharmaceuticals.
In this capacity, he held global responsibility for multiple drug
discovery programs, including the successful discovery and development
of Velcade® (bortezomib), a proteasome inhibitor for two
different blood cancers: multiple myeloma and relapsed mantle cell
lymphoma. He previously held senior management positions with
organizations such as LeukoSite, ProScript, Inc. and Boehringer
Ingelheim, where he successfully discovered the drug Viramune®
(nevirapine) for HIV. Dr. Adams’ awards include the 2012 Warren Alpert
Foundation Prize for his role in the discovery and development of
bortezomib, the 2012 C. Chester Stock Award Lectureship from Memorial
Sloan-Kettering Cancer Center, and the 2001 Ribbon of Hope Award for
Velcade® from the International Myeloma Foundation.
The funds raised through corporate and individual contributions during
the Light The Night® Walk help to find cures and better
therapies for leukemia, lymphoma, Hodgkin disease and myeloma. Donations
also provide information, education and support for patients and their
families.
“Light The Night Walk gives hope to patients and their families and lets
them know they are not alone in their battle against cancer,” said
Sharon Klein, executive director of the Massachusetts chapter of the LLS.
To find out more about forming a team or participating in a Light The
Night walk, contact the Massachusetts Chapter at 508-810-1342, or www.lightthenight.org
About The Leukemia & Lymphoma Society
The Leukemia &
Lymphoma Society® (LLS) is the world’s largest voluntary
health agency dedicated to blood cancer. The LLS mission: Cure leukemia,
lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life
of patients and their families. LLS funds lifesaving blood cancer
research around the world and provides free information and support
services.
Founded in 1949 and headquartered in White Plains, NY, LLS
has chapters throughout the United States and Canada. To learn more,
visit www.LLS.org
or contact the Information Resource Center at (800) 955-4572, Monday
through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.
About Infinity’s “Sparks of Inspiration” Campaign
Infinity
Pharmaceuticals, Inc. is an innovative biopharmaceutical company
dedicated to discovering, developing and delivering best-in-class
medicines to people with difficult-to-treat diseases. Throughout
September, Infinity is observing National Blood Cancer Awareness Month,
joining patients, healthcare providers and patient organizations in
raising public awareness of blood cancers and the need for continued
research for novel treatment options. In support of patients and their
loved ones, Infinity is launching the Sparks
of Inspiration campaign. Infinity encourages the submission of
stories along with photos and illustrations honoring friends, family
members or loved ones affected by blood cancer. For each submission
received, Infinity will make a $10 donation to the Leukemia & Lymphoma
Society, up to a total of $5,000. Submissions can be made through
Infinity’s website www.infi.com.
Submissions will be accepted through September 30, 2013.
Copyright Business Wire 2013